• Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Bulgaria Croatia France Germany +9
  • Study on the Effectiveness and Safety of IMVT-1402 for Adults with Graves’ Disease

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Hungary Italy Poland Spain
  • Study on Early vs. Late Restart of Anticoagulation with Edoxaban, Apixaban, and Warfarin for Patients with Chronic Subdural Hematoma and Atrial Fibrillation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Finland Sweden
  • Study on Visugromab with Pembrolizumab, Pemetrexed, and Carboplatin for First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    Bulgaria Germany Italy Poland Romania Spain
  • Study of Simvastatin with Nivolumab and Oxaliplatin for Patients with Advanced Stomach or Esophageal Cancer with ARID1A Mutation

    Recruiting

    2 1 1 1
    Italy
  • Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Italy Spain
  • Study on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium The Netherlands
  • Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark Finland Germany +2
  • Study on the Effects of Low Dose Choriogonadotropin Alfa in Women with Diminished Ovarian Reserve Undergoing IVF/ICSI

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Long-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis

    Recruiting

    2 1 1
    Investigated Drugs:
    Czechia France Germany Italy The Netherlands Poland +1

powered by